Actively Recruiting

Age: 18Years +
All Genders
NCT05728996

Netherlands Cohort Study on Acute HIV Infection

Led by Prof. Jan Prins · Updated on 2023-02-15

183

Participants Needed

1

Research Sites

678 weeks

Total Duration

On this page

Sponsors

P

Prof. Jan Prins

Lead Sponsor

U

UMC Utrecht

Collaborating Sponsor

AI-Summary

What this Trial Is About

Investigation of the size, variability and localization of the (pro) viral reservoir and the properties of HIV-specific immune response related to "post-treatment viral remission' achievement and / or duration. In addition we will study the factors that determine latency in the different host cells, their sensitivity to induction of replication competent virus by various agents and the potential application of these agents in "post-treatment viral remission". This all will be studied in patients included during acute phase of the infection who start antiretroviral therapy immediately upon diagnosis.

CONDITIONS

Official Title

Netherlands Cohort Study on Acute HIV Infection

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Provide written informed consent for sample storage and genetic testing
  • Provide separate written consent for invasive procedures like leukapheresis, biopsies, lymph node excision, and lumbar puncture
  • Be 18 years of age or older
  • Have an acute HIV-1 infection defined by Fiebig stages I to IV, or meet specific criteria for stages V and VI
  • Female participants must agree to use effective contraception
Not Eligible

You will not qualify if you...

  • Have contraindications to the proposed cART treatment, such as impaired kidney function
  • Have a mental disorder that could interfere with adherence to treatment or study participation
  • Use immunosuppressive medication or have other diseases causing immune deficiency

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Amsterdam UMC, location AMC

Amsterdam, North Holland, Netherlands, 1105 AZ

Actively Recruiting

Loading map...

Research Team

P

Pien van Paassen, MD

CONTACT

G

Godelieve de Bree, MD PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here